🇺🇸 FDA
Patent

US 10577605

Induced exon inclusion in spinal muscle atrophy

granted A61PA61P21/02A61P25/00

Quick answer

US patent 10577605 (Induced exon inclusion in spinal muscle atrophy) held by Sarepta Therapeutics, Inc. expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P21/02, A61P25/00